Chemoinformaics analysis of benzyl 6-O- á-L-rahamnopyranosyl-b-D-glucopyranoside
Molecular Weight | 97.015 | nRot | 0 |
Heavy Atom Molecular Weight | 97.015 | nRig | 1 |
Exact Molecular Weight | 96.9901 | nRing | 0 |
Solubility: LogS | -0.385 | nHRing | 0 |
Solubility: LogP | 0.367 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 6 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 0 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 5.813 |
nHD | 0 | BPOL | 4.207 |
QED | 0.434 |
Synth | 3.395 |
Natural Product Likeliness | -0.56 |
NR-PPAR-gamma | 0.023 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.401 |
MDCK | 0.0000238 |
BBB | 0.908 |
PPB | 0.404443 |
VDSS | 1.941 |
FU | 0.612514 |
CYP1A2-inh | 0.343 |
CYP1A2-sub | 0.847 |
CYP2c19-inh | 0.109 |
CYP2c19-sub | 0.807 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.295 |
CYP2d6-inh | 0.029 |
CYP2d6-sub | 0.29 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.268 |
CL | 7.832 |
T12 | 0.625 |
hERG | 0.02 |
Ames | 0.805 |
ROA | 0.948 |
SkinSen | 0.869 |
Carcinogencity | 0.76 |
EI | 0.979 |
Respiratory | 0.983 |
NR-Aromatase | 0.011 |
Antiviral | No |
Prediction | 0.933 |